I don't think the FDA will reject it. I just don't believe their profits from the sale of Fluticare OTC will be as high as anticipated. I still believe INNV will get their approval in Q1 and not sooner. However, if not approved by end of Q2, then no approval because there is really no need.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.